JP2024539126A5 - - Google Patents
Info
- Publication number
- JP2024539126A5 JP2024539126A5 JP2024523582A JP2024523582A JP2024539126A5 JP 2024539126 A5 JP2024539126 A5 JP 2024539126A5 JP 2024523582 A JP2024523582 A JP 2024523582A JP 2024523582 A JP2024523582 A JP 2024523582A JP 2024539126 A5 JP2024539126 A5 JP 2024539126A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- natural killer
- polynucleotide
- polynucleotide according
- killer cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163257608P | 2021-10-20 | 2021-10-20 | |
| US63/257,608 | 2021-10-20 | ||
| PCT/US2022/078331 WO2023069969A1 (en) | 2021-10-20 | 2022-10-19 | Engineering nk cells with a car construct with optimal signaling |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539126A JP2024539126A (ja) | 2024-10-28 |
| JP2024539126A5 true JP2024539126A5 (cg-RX-API-DMAC7.html) | 2025-10-15 |
Family
ID=86058649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523582A Pending JP2024539126A (ja) | 2021-10-20 | 2022-10-19 | 最適なシグナル伝達を有するcar構築物によるnk細胞の操作 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240408203A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4419128A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024539126A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240099309A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118265535A (cg-RX-API-DMAC7.html) |
| AR (1) | AR127405A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022369294A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3233096A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2024002936A2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024004772A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202330586A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023069969A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121337979A (zh) * | 2025-04-03 | 2026-01-16 | 上海恩凯细胞技术有限公司 | 新型嵌合抗原受体修饰的免疫细胞及其在制备药物中的用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110475857B (zh) * | 2017-01-05 | 2023-07-18 | 韩国生命工学研究院 | 表达抗-可替宁嵌合抗原受体的天然杀伤细胞 |
| US11541076B2 (en) * | 2017-01-13 | 2023-01-03 | Celdara Medical, Llc | Chimeric antigen receptors targeting TIM-1 |
| CN107573419A (zh) * | 2017-01-24 | 2018-01-12 | 深圳市体内生物医药科技有限公司 | 一种增强t细胞抗肿瘤活性的核酸分子 |
| EP3668899A4 (en) * | 2017-08-18 | 2020-09-02 | Celdara Medical, LLC | CELL-BASED THERAPIES TARGETING DISEASE-ASSOCIATED MOLECULAR MEDIATORS OF FIBROTIC, INFLAMMATORY AND AUTOIMMUNE DISEASES |
| JP2022548902A (ja) * | 2019-09-18 | 2022-11-22 | ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム | Bcma陽性腫瘍を標的とするためのナチュラルキラー細胞の操作方法 |
| US20240189357A1 (en) * | 2021-04-14 | 2024-06-13 | Board Of Regents, The University Of Texas System | Chimeric antigen receptors to target cd5-positive cancers |
| EP4332118A1 (en) * | 2021-04-29 | 2024-03-06 | Korea Research Institute of Bioscience and Biotechnology | Novel anti-cd5 chimeric antigen receptor and immune cell expressing same |
| CA3221568A1 (en) * | 2021-05-26 | 2022-12-01 | Board Of Regents, The University Of Texas System | Chimeric antigen receptor to target hla-g-positive cancers |
| JP2024525609A (ja) * | 2021-07-09 | 2024-07-12 | ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム | Trop-2陽性癌を標的とするキメラ抗原受容体 |
-
2022
- 2022-10-19 CA CA3233096A patent/CA3233096A1/en active Pending
- 2022-10-19 EP EP22884661.4A patent/EP4419128A4/en active Pending
- 2022-10-19 MX MX2024004772A patent/MX2024004772A/es unknown
- 2022-10-19 JP JP2024523582A patent/JP2024539126A/ja active Pending
- 2022-10-19 AU AU2022369294A patent/AU2022369294A1/en active Pending
- 2022-10-19 WO PCT/US2022/078331 patent/WO2023069969A1/en not_active Ceased
- 2022-10-19 AR ARP220102843A patent/AR127405A1/es unknown
- 2022-10-19 US US18/699,702 patent/US20240408203A1/en active Pending
- 2022-10-19 KR KR1020247016522A patent/KR20240099309A/ko active Pending
- 2022-10-19 TW TW111139574A patent/TW202330586A/zh unknown
- 2022-10-19 CN CN202280076663.4A patent/CN118265535A/zh active Pending
-
2024
- 2024-03-11 CO CONC2024/0002936A patent/CO2024002936A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240041933A1 (en) | Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof | |
| Bontkes et al. | Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells | |
| JP2024138280A5 (cg-RX-API-DMAC7.html) | ||
| JP7334985B2 (ja) | 免疫細胞で発現される膜結合抗サイトカイン非シグナル伝達バインダーによるヒトサイトカインの中和 | |
| JP2023036712A (ja) | 操作された造血幹細胞/前駆細胞及び非tエフェクター細胞、ならびにその使用 | |
| JP2024527559A5 (cg-RX-API-DMAC7.html) | ||
| JP2021525534A5 (cg-RX-API-DMAC7.html) | ||
| BR112019022356A2 (pt) | Reagentes de partícula oligoméricos e métodos de uso dos mesmos | |
| JP2024514203A5 (cg-RX-API-DMAC7.html) | ||
| JP2024521185A5 (cg-RX-API-DMAC7.html) | ||
| AU2016306209A1 (en) | Bispecific CAR T-cells for solid tumor targeting | |
| JP2017525364A (ja) | 免疫細胞を惹起及び/又は活性化するための免疫応答刺激性サイトカインを発現する遺伝子改変型間葉系幹細胞 | |
| US12280092B2 (en) | Reprogrammed T cell-like NK cells | |
| CN106535925A (zh) | 基于car的免疫治疗 | |
| JP2024525609A5 (cg-RX-API-DMAC7.html) | ||
| JP2022548902A5 (cg-RX-API-DMAC7.html) | ||
| CN111918964A (zh) | 促进免疫细胞增殖的方法 | |
| CN114599784A (zh) | 具有cd45ra+和ccr7+的细胞表面标志物的t细胞的制备方法 | |
| JP2022513099A5 (cg-RX-API-DMAC7.html) | ||
| Weinstein-Marom et al. | Combined expression of genetic adjuvants via mRNA electroporation exerts multiple immunostimulatory effects on antitumor T cells | |
| EP4476246A2 (en) | Recombinant proteins that stimulate an immune response in the presence of naturally inhibitory ligand binding | |
| JP6684211B2 (ja) | B細胞集団の製造方法 | |
| US20250073268A1 (en) | Chimeric cd40 polypeptides and methods of use in immunotherapy | |
| RU2024113197A (ru) | Модифицирование nk-клеток конструкцией car с оптимальной передачей сигнала | |
| WO2025166113A1 (en) | Cell-free implants for in vivo recruitment, activation, and reprogramming of immune cells |